Literature DB >> 3467893

Occurrence of leukoplakia and some other oral white lesions among 20,333 adult Swedish people.

T Axéll.   

Abstract

Among 20,333 people aged 15 yr or above, the prevalences of oral white lesions were calculated based on a partly new classification. The total prevalences were: cheek and lip biting 5.1%, smoker's palate 1.1%, frictional white lesion 5.5%, snuff dipper's lesion 8.0%, preleukoplakia 6.4% and leukoplakia 3.6%. If all these lesions were pooled, the prevalence was 24.8% and if only the entities cheek and lip biting and smoker's palate were excluded it became 20.1%. If weak "preleukoplakic" lesions were excluded from the latter figure the prevalence for marked whitish lesions was 13.8%. Etiologic and clinical subgroups of leukoplakia showed the following prevalences: using the etiologic subgroups, idiopathic leukoplakia 0.7% and tobacco-associated leukoplakia 2.9%; using the clinical subgroups, homogeneous leukoplakia 3.5% and non-homogeneous leukoplakia 0.3%. The intraoral location pattern of leukoplakias was preponderant in the commissural and buccal areas. However, the idiopathic leukoplakias showed a somewhat more even distribution and thus a more similar distribution to that of oral cancer.

Entities:  

Mesh:

Year:  1987        PMID: 3467893     DOI: 10.1111/j.1600-0528.1987.tb00479.x

Source DB:  PubMed          Journal:  Community Dent Oral Epidemiol        ISSN: 0301-5661            Impact factor:   3.383


  18 in total

1.  Pan masala habits and risk of oral precancer: A cross-sectional survey in 0.45 million people of North India.

Authors:  Divya Mehrotra; Sumit Kumar; Shambhavi Mishra; Sandeep Kumar; Prashant Mathur; C M Pandey; Arvind Pandey; Kishore Chaudhry
Journal:  J Oral Biol Craniofac Res       Date:  2016-12-29

2.  Clinicopathologic Correlation of White, Non scrapable Oral Mucosal Surface Lesions: A Study of 100 Cases.

Authors:  Mohammed Abidullah; Vandana Raghunath; Tanveer Karpe; Syed Akifuddin; Shahid Imran; Venkata Naga Nalini Dhurjati; Mohammed Ahtesham Aleem; Farheen Khatoon
Journal:  J Clin Diagn Res       Date:  2016-02-01

3.  Increased leukocyte mitochondrial DNA copy number is associated with oral premalignant lesions: an epidemiology study.

Authors:  Yonggang He; Yilei Gong; Jian Gu; J Jack Lee; Scott M Lippman; Xifeng Wu
Journal:  Carcinogenesis       Date:  2014-04-17       Impact factor: 4.944

4.  Photodynamic Therapy - A Non-invasive Treatment Modality for Precancerous Lesions.

Authors:  Kotya Naik Maloth; Nagalaxmi Velpula; Srikanth Kodangal; Mithare Sangmesh; Kiran Vellamchetla; Sridevi Ugrappa; Nagajyothi Meka
Journal:  J Lasers Med Sci       Date:  2016-01-07

Review 5.  Leuloplakia - review of a potentially malignant disorder.

Authors:  Mohammed Abidullah; G Kiran; Kavitha Gaddikeri; Swetha Raghoji; Shilpa Ravishankar T
Journal:  J Clin Diagn Res       Date:  2014-08-20

6.  Feasibility of recruitment to an oral dysplasia trial in the United Kingdom.

Authors:  Paul Nankivell; Janet Dunn; Michael Langman; Hisham Mehanna
Journal:  Head Neck Oncol       Date:  2012-06-25

7.  Derivation and validation of a risk-factor model for detection of oral potentially malignant disorders in populations with high prevalence.

Authors:  H K Amarasinghe; N W Johnson; R Lalloo; M Kumaraarachchi; S Warnakulasuriya
Journal:  Br J Cancer       Date:  2010-07-13       Impact factor: 7.640

8.  Idiopathic linear leukoplakia of gingiva: A rare case report.

Authors:  N Sapna; K L Vandana
Journal:  J Indian Soc Periodontol       Date:  2010-07

9.  The morbidity of oral mucosal lesions in an adult Swedish population.

Authors:  Jairo Robledo-Sierra; Ulf Mattsson; Tage Svedensten; Mats Jontell
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2013-09-01

10.  Study over the clinical picture and histopathology of leukoplakia and to establish the correlation between causative factors in the patients of Garhwal hill region.

Authors:  Ravindra S Bisht; Amit K Singh; Vikas Sikarwar; Anshuman Darbari
Journal:  Natl J Maxillofac Surg       Date:  2013-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.